Gene: CACNG6
Official Full Name: calcium voltage-gated channel auxiliary subunit gamma 6provided by HGNC
Gene Summary: Voltage-dependent calcium channels are composed of five subunits. The protein encoded by this gene represents one of these subunits, gamma, and is one of two known gamma subunit proteins. This particular gamma subunit is an integral membrane protein that is thought to stabilize the calcium channel in an inactive (closed) state. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family and is located in a cluster with two family members that function as transmembrane AMPA receptor regulatory proteins (TARPs). Alternative splicing results in multiple transcript variants. Variants in this gene have been associated with aspirin-intolerant asthma. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19122 | CACNG6 Knockout cell line (A549) | Human | CACNG6 | 1:3~1:4 | Negative | Online Inquiry |
CACNG6 Gene Knockout Cell Lines refer to genetically engineered cell lines that have undergone targeted deletion of the calcium channel gene CACNG6. This gene encodes a subunit of voltage-gated calcium channels, which play a vital role in calcium ion signaling pathways, influencing numerous cellular processes such as excitation-contraction coupling in muscle cells, neurotransmitter release in neurons, and overall homeostasis in various tissues.
The primary function of the CACNG6 Gene Knockout Cell Lines is to enable researchers to investigate the specific role of CACNG6 in cellular physiology and pathophysiology. By eliminating the gene's expression, researchers can elucidate the downstream effects of calcium channel dysfunction, providing insights into diseases linked with calcium signaling abnormalities, including cardiac arrhythmias and neurological disorders. The loss of CACNG6 can also facilitate the study of compensatory mechanisms that might activate alternate signaling pathways, thereby enhancing our understanding of cellular responses to calcium deregulation.
In research and clinical applications, these knockout cell lines serve as invaluable tools for drug discovery, toxicology testing, and mechanistic studies of diseases. They allow for high-throughput screening of pharmacological compounds targeting calcium signaling pathways, thereby representing a significant advancement over traditional models. The reduction in background noise and increased specificity of knockout cell lines make them superior to wild-type models, which may contain compensatory adaptations.
Furthermore, compared to alternative genetic models, such as transgenic or knockdown approaches, CACNG6 Gene Knockout Cell Lines offer a complete disruption of gene function, thereby leading to more definitive conclusions regarding the gene's role. This specificity is crucial for developing targeted therapies aimed at modulating calcium signaling.
For researchers and clinicians focused on unraveling the complexities of calcium-mediated signaling and its implications in health and disease, CACNG6 Gene Knockout Cell Lines present a powerful research tool. Our company, with extensive expertise in genetic modification technologies and cell line development, is committed to delivering high-quality, reproducible models that drive transformative discoveries in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.